Overnutrition, mTOR signaling, and cardiovascular diseases. - Test2 - elhamkhani - TriplyDB

Overnutrition, mTOR signaling, and cardiovascular diseases.

Overnutrition, mTOR signaling, and cardiovascular diseases.

http://www.wikidata.org/entity/Q34519316

about

Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy Erythropoietin and diabetes mellitus Vascular stiffness in insulin resistance and obesity Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy Review: Metabolic Regulation of Inflammation in Osteoarthritis New Insights for Oxidative Stress and Diabetes Mellitus Novel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease Design of pathway preferential estrogens that provide beneficial metabolic and vascular effects without stimulating reproductive tissues Interaction of Adipogenesis and Angiogenesis in Dietary-Induced Obesity.Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice.Endothelial Mineralocorticoid Receptor Deletion Prevents Diet-Induced Cardiac Diastolic Dysfunction in Females.Endothelial Mineralocorticoid Receptor Mediates Diet-Induced Aortic Stiffness in Females Fructose, but not glucose, impairs insulin signaling in the three major insulin-sensitive tissues Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension Regulation of the epithelial Na+ channel by the mTORC2/SGK1 pathway.Physiological and therapeutic effects of carnosine on cardiometabolic risk and disease.The endothelial mineralocorticoid receptor: mediator of the switch from vascular health to disease.Role of mineralocorticoid receptor activation in cardiac diastolic dysfunction.30 YEARS OF THE MINERALOCORTICOID RECEPTOR: The role of the mineralocorticoid receptor in the vasculature.Anorexic response to rapamycin does not appear to involve a central mechanism.Aging: Molecular Pathways and Implications on the Cardiovascular System.mTOR: Driving apoptosis and autophagy for neurocardiac complications of diabetes mellitus.Contribution of Maladaptive Adipose Tissue Expansion to Development of Cardiovascular Disease.Folic acid inhibits dedifferentiation of PDGF-BB-induced vascular smooth muscle cells by suppressing mTOR/P70S6K signaling Antioxidant Effects of the Quercetin in the Jejunal Myenteric Innervation of Diabetic Rats.CD38 deficiency suppresses adipogenesis and lipogenesis in adipose tissues through activating Sirt1/PPARγ signaling pathway.Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFκB/mTOR/P70S6K signaling cascade.mTOR-Dependent Cell Proliferation in the Brain.The role of mineralocorticoid receptor signaling in the cross-talk between adipose tissue and the vascular wall.NLRC3 regulates cellular proliferation and apoptosis to attenuate the development of colorectal cancer.Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease.Upstream signalling of mTORC1 and its hyperactivation in type 2 diabetes (T2D).Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.Folic acid delays development of atherosclerosis in low-density lipoprotein receptor-deficient mice.

P2860

Q26749047-FD4A6C7A-5BD8-40E7-9D26-71478DDEBA22 Q26775037-199BAF59-7073-430A-BAA6-1B3554CEE977 Q26777878-C4096B1E-CD8B-440F-AFD8-763ABA14F9D1 Q26796220-A28C1AAE-5C76-4344-8683-08D1DF4B01B9 Q28066377-A65EFC6E-6C9F-4B23-B8AE-B73DC4FFCB5C Q28079875-5772843C-6217-4683-AD96-EE04A1B12ABC Q28080679-D139AA89-EDA8-4EC0-A706-5BE619FA0206 Q28085715-C06C4FAE-8B42-4BA0-BED9-88DBA1B512D2 Q28828683-0730B9B5-8CC4-439B-876B-0A6801E5A540 Q35769629-BAF7A5A2-C41E-433E-9872-F2EB29B3DB4E Q36000073-AC9C6738-1133-4298-B54B-DD8C6C878968 Q36277736-72E40403-5B84-4A36-A4B5-861F594C22C5 Q36703486-D1F39299-9816-4972-AD4F-EF28CABF314E Q36914719-A42D6B79-1223-4C28-9FCC-4C64A1921D86 Q36996364-65F61EEE-DB2C-447D-A12B-7F027EE17FDC Q38545109-BD09C811-1DA2-4D17-B6D8-A244B0D58A9F Q38777574-E80FEA12-F4E4-48C1-9D91-6A2D6F5317F0 Q39032836-F111AFDC-0668-4D2F-A314-1E2696A26050 Q39042819-9412DAF7-F554-4AC4-BF4F-8DDA976EC70E Q39386976-6414B392-56E6-41BF-BB67-95FA97985F75 Q39731425-F262D9B6-7E0E-49F4-9057-D83043503D9C Q41509997-FC9ABF4D-6172-4C4A-B48A-519D948408EC Q42031136-02606A09-619A-48F8-93BE-D81EFFE82D63 Q42054611-1D139AC4-4E1F-4A5D-AF00-DE4B60694DD5 Q42068247-D0A2B80D-8092-44C8-AE27-266C927690D4 Q42323647-B9AF434B-0193-4249-87E7-03362ACA87DB Q42798222-4CD947FE-75B0-4B13-8BA5-139B33360E12 Q46254229-3E40D0EC-D0A3-4B7D-8DFC-A999BFFC7E00 Q47231432-8922A521-8587-4258-BCB6-F1174920ECB6 Q47788950-86469881-7A0E-4889-9786-5CE1979F1137 Q48300450-07E7D3CF-3CF0-41DA-A637-A1F3D719E691 Q48339739-D161837C-AFD8-4A5D-951B-A00DEEBC65ED Q49413554-9D6CC0C6-07F4-484E-817C-E30AD4E5B0E6 Q51761339-BFD4B7E5-E437-40AB-B018-99398D5909CA Q52640082-D7F10B6C-957E-40B4-88C9-6B9132BBABEC

P2860

Overnutrition, mTOR signaling, and cardiovascular diseases.

http://www.wikidata.org/entity/Q34519316

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Overnutrition, mTOR signaling, and cardiovascular diseases.

@ast

Overnutrition, mTOR signaling, and cardiovascular diseases.

@en

Overnutrition, mTOR signaling, and cardiovascular diseases.

@nl

type

label

Overnutrition, mTOR signaling, and cardiovascular diseases.

@ast

Overnutrition, mTOR signaling, and cardiovascular diseases.

@en

Overnutrition, mTOR signaling, and cardiovascular diseases.

@nl

prefLabel

Overnutrition, mTOR signaling, and cardiovascular diseases.

@ast

Overnutrition, mTOR signaling, and cardiovascular diseases.

@en

Overnutrition, mTOR signaling, and cardiovascular diseases.

@nl

P1433

Q34519316-4BDC90A3-A6B4-4069-A035-08FBB64679F8

P1476

Q34519316-ECDEFA56-0ACC-4A1D-8F89-EFE51DF0353E

P2093

Q34519316-32F01DD7-C1D7-48E5-AC5B-AB0E66678CE7

Q34519316-811170CA-5B97-4EBC-A4DF-94FE936E3C51

Q34519316-86477878-3C4D-49BD-812F-C50884E11C91

Q34519316-C980D3E0-B170-4BD1-AC3B-B33B388936A5

P2860

Q34519316-01C76F00-049C-4F42-96F7-A7D9500DB0B3

Q34519316-01D59AD2-CE4E-4B94-B01D-D5E8A4C3597E

Q34519316-04FB330A-1057-4C8F-A566-F81F04229B8C

Q34519316-0743679E-620C-4852-877E-3E7ECE8FA5FD

Q34519316-0B50B36B-CEEB-4D0F-A756-7E7999AB5140

Q34519316-0B7CB1E8-639C-499E-9CA3-E21290C6ED05

Q34519316-0FA972A6-B48E-439C-8139-0CDEB6DC338B

Q34519316-108D6F9D-E7B4-4D64-BBFD-BF3BFCFF366A

Q34519316-12337CE1-C4CC-4CD4-A9B4-920D2EEB3B2E

Q34519316-1338A6EB-8873-491D-A55C-EE479D6FC904

P304

Q34519316-78925CE1-FB7A-411B-9F24-DF9362BEB506

P31

Q34519316-4a257261-05c8-46d4-9255-c4e83325d369

Q34519316-A7F76E85-96B4-4399-8F21-7E64397CB9F4

P356

Q34519316-116D96A6-E347-42DD-890B-97121D334C98

P433

Q34519316-5066EC51-56E7-4405-BC82-7EADFC033C70

P478

Q34519316-EEF1114F-6DE7-4907-B595-D8C0BEC32859

P577

Q34519316-2D982892-0081-4DA6-9C6A-D0A7B260D101

P698

Q34519316-49E74B4F-E437-413D-9DC1-15203F58C8C9

P921

Q34519316-1F84D980-CF69-43AC-82CF-B8252AD9038F

P932

Q34519316-4634C646-5A13-4594-8FFF-7EC2FDA9B897

P356

AJPREGU.00262.2014

P1433

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

P1476

Overnutrition, mTOR signaling, and cardiovascular diseases.

@en

P2093

Annayya R Aroor

http://www.w3.org/2001/XMLSchema#string

Guanghong Jia

http://www.w3.org/2001/XMLSchema#string

James R Sowers

http://www.w3.org/2001/XMLSchema#string

Luis A Martinez-Lemus

http://www.w3.org/2001/XMLSchema#string

P2860

Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids

mTOR signaling in growth control and disease

The mTOR pathway and integrating immune regulation

Linking obesity with type 2 diabetes: the role of T-bet

Over-nutrition and metabolic cardiomyopathy

Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases

Rapalogs and mTOR inhibitors as anti-aging therapeutics

The PI3K/AKT/mTOR signaling pathway is overactivated in primary aldosteronism

AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1

Multiple site acetylation of Rictor stimulates mammalian target of rapamycin complex 2 (mTORC2)-dependent phosphorylation of Akt protein.

P304

R1198-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPREGU.00262.2014

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

307

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25253086

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

4233289

http://www.w3.org/2001/XMLSchema#string